Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Incurable Platinum Refractory Germ Cell Tumors”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Testing effectiveness (Phase 2)Study completedNCT03760081
What this trial is testing

Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors

Who this might be right for
Incurable Platinum Refractory Germ Cell TumorsTumors
Astellas Pharma Global Development, Inc. 19
Testing effectiveness (Phase 2)Ended earlyNCT02499952
What this trial is testing

Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors

Who this might be right for
Germ Cell NeoplasmsTesticular NeoplasmsNon Seminomatous Germ Cell Tumors+4 more
Nasser Hanna, M.D. 12